Rznomics

476830· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩31,500+18.64%

2026-08-04

Financials

Valuation Metrics

Rznomics's Market Cap is ₩8837B. At end of 2025 it was ₩2.3T. Ranked #313 of 2,436 in KR market (top 13%), #83 of 1,649 on KOSDAQ (top 5%), #36 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 15%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	883.75B KRW	KR#313/2,436 Sec#36/234
Revenue	8.29B KRW	KR#2,304/2,436 Sec#182/234
Net Income	-103.81B KRW	KR—/2,436 Sec—/234
Total Assets	58.59B KRW	KR#2,099/2,436 Sec#184/234
Net Assets	51.75B KRW	KR#1,849/2,436 Sec#158/234
Value
P/B	17.08x	KR#2,381/2,436 Sec#219/234
P/S	106.65x	KR#2,390/2,436 Sec#211/234
FCF Yield	-1.23%	KR—/2,436 Sec—/234
Profitability
Op. Margin	-223.55%	KR#2,345/2,436 Sec#189/234
Financial Health
Debt Ratio	113.22%	KR#512/2,436 Sec#69/234
FCF	-10.90B KRW	KR#1,738/2,436 Sec#152/234
Cash	7.83B KRW	KR#1,804/2,436 Sec#155/234
Current Ratio	7.66x	KR#165/2,436 Sec#39/234
Performance
1M Return	-24.46%	KR#2,295/2,436 Sec#226/234
From 52W High	-74.31%	KR#2,267/2,436 Sec#211/234
1Y MDD	-82.54%	KR#2,336/2,436 Sec#223/234
Trading
Volume	856,457 shares	KR#160/2,436 Sec#9/234
Foreign Own.	12.24%	KR#406/2,436 Sec#37/234
Per Share
EPS	-4,859 KRW	KR—/2,436 Sec—/234
BPS	1,857 KRW	KR#2,072/2,436 Sec#173/234